CAS: 2510-36-3; 3,5-Dimethylisoxasole-4-Carboxylic Acid

该化合物是一种有机化合物,其特征为异氧氮环结构,其特点是五人环,含有氮和氧原子;该化合物有两组甲基,附于异氧环的3和5个位置,有助于其独特性能;4号位置上存在一个箱状酸性功能组,增强了其酸性和反应力,使其在各种化学反应中有用;该化合物通常是白到白的晶状固体,在水和酒精等极地溶剂中可溶解;该化合物因其潜在的生物活动,包括反炎和抗微生物特性,对医药化学和研究感兴趣;该化合物的分子结构允许进行各种修改,这些修改可导致衍生物的开发,并产生强化的药理学效应;与许多有机化合物一样,应观测到适当的处理和安全措施,因为如浸泡或不当管理,可能会对健康造成危害.

结构式图片

相似化合物

54593-26-9 19788-36-4 17147-42-1

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

3,5-二甲基异噁唑-4-甲酸乙脂 Ethyl 3,5-Dimethylisoxazole-4-Carboxylate 17147-42-1
(3,5-二甲基-4-异恶唑基)甲醇 4-Hydroxymethyl-3,5-Dimethylisoxazole 19788-36-4
3,4,5-三甲基恶唑 3,4,5-Trimethylisoxazole 10557-82-1

合成工艺路线路线简述

  • 合成目标产物 3,5-Dimethylisoxazole-4-Carboxylic Acid 主要起始原料 Ethyl 3,5-Dimethylisoxazole-4-Carboxylate
  • (文献来源)合成步骤主要原料 Ethyl 3,5-Dimethylisoxazole-4-Carboxylate
3,5-二甲基异噁唑-4-甲酸乙脂置于sodium Hydroxide体系中,化学反应生成3,5-二甲基异噁唑-4-羧酸
参考文献:Claisen,Justus Liebigs Annalen Der Chemie,1893,Vol. 277,P. 174
标题:Claisen,Justus Liebigs Annalen Der Chemie,1893,Vol. 277,P. 174

海关参考信息

专利信息


专利号:US-7179918-B2
优先权日:2001-06-11
标 题:HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
发明人:CANAN KOCH STACIE S; ALEXANDER THERESE N; BURKE BENJAMIN J; JEWELL TANYA M; KUCERA DAVID J; LINTON MARIA ANGELICA; MITCHELL JR LENNERT J; REICH SIEGFRIED H; SKALITZKY DONALD J; TATLOCK JOHN H; VARNEY MICHAEL D; VIRGIL SCOTT C; WEBBER STEPHEN E; WORLAND STEPHEN T; BARVIAN MARK; BOLTON GARY; BOYER JR FREDERICK EARL; MACHAK JEFFREY J; HOLLER TOD; MURPHY SEAN T; MELNICK MICHAEL; JOSYULA VARA PRASAD
权利人:AGOURON PHARMA
摘要:Compounds of the formula: n nwhere the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

专利号:EP-3515880-B1
优先权日:2017-03-17
标题:Methods and compositions for synthesis of encoded libraries
发明人:LI JIN; MORGAN BARRY A; Wan jinqiao; DOU DENGFENG; LIU GUANSAI; CHANG YONG; CHEN QIUXIA; WANG XING; XU YANSHAN; HU DONGYAN; LIU JIAN; CHENG XUEMIN
权利人:HITGEN INC

专利号:US-2020149034-A1
优先权日:2017-03-17
标题:Methods and Compositions for Synthesis of Encoded Libraries

专利号:US-7169932-B2
优先权日:2001-06-11
标题:HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
发明人:KUCERA DAVID JOHN; SCOTT ROBERT WILLIAM
权利人:PFIZER
摘要:Compounds of the formula: n nwhere the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

专利号:US-7094909-B2
优先权日:2001-06-11
标 题 :HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
发明人:KUCERA DAVID JOHN; SCOTT ROBERT WILLIAM
权利人:AGOURON PHARMA
摘要:The present invention concerns processes for preparing compounds of formula (I-H), or a prodrug, pharmaceutically active metabolite, or pharmaceutically active salt or solvate thereof, n nwhich are useful as inhibitors of the HIV protease enzyme.

专利号:US-6852744-B2
优先权日:2000-08-30
标题:Pyrrolidine derivatives and their use as chymase inhibitor
发明人:DEGUCHI TAKASHI; SHIRATAKE RYOTARO; SATO FUMINORI; FUJITANI BUICHI; HONDA YAYOI; KIYOSHI AKIHIKO; NOTAKE MITSUE; SHOWELL GRAHAM ANDREW; BOYLE ROBERT GEORGE; KLAIR SUKHBINDER SINGH
权利人:DAINIPPON PHARMACEUTICAL CO
摘要:Novel pyrrolidine derivatives, being useful as chymase inhibitor or intermediate for synthesis of the active compounds, which has the formula (I): wherein R<1 >is cycloalkyl, substituted or unsubstituted phenyl or naphthyl, indanyl, thienyl, furyl, substituted or unsubstituted indolyl, benzofuryl, substituted or unsubstituted benzothienyl, etc.; R<2 >is H, alkyl, phenyl-lower alkyl, cycloalkyl or cycloalkyl-lower alkyl; R<3 >is (i) substituted or unsubstituted monocyclic heterocyclic group, (ii) substituted or unsubstituted benzene- or pyridine-fused heterocyclic group, or (iii) a group (a): R<4 >and R<5 >are independently H or OH, but R<4 >and R<5 >are not simultaneously H, or both form oxo; n is 0, 1, 2 or 3; or a salt thereof.
南京新斯特生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.nstbio.com
企业联系电话:025-85331029,18915981017👤
📞南京新斯特生物科技有限公司 ⚠️参考联系方式
联系人:杨女士
电话:025-85331029,18915981017
手机:18915981017
传真:025-85331829
邮箱:sales@nstbio.com
通信地址: 江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
邮编: 210010
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Zhang, M.; Su, W., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 3, 113.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知